L
LSL Pharma Group Inc
XTSX:LSL
LSL Pharma Group Inc
XTSX:LSL
Price:
0.415
CAD
5.06%
Market Closed
Market Cap:
CA$52.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
LSL Pharma Group Inc
PP&E Net
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
LSL Pharma Group Inc
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
LSL Pharma Group Inc
XTSX:LSL
|
PP&E Net
CA$23m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
PP&E Net
$2.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
PP&E Net
$15.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
23%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
PP&E Net
CA$21.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
PP&E Net
CA$474k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-4%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
PP&E Net
$453k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
4%
|
|
No Stocks Found
LSL Pharma Group Inc
Glance View
LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. The firm specializes in the development, manufacturing, and distribution of natural health products and dietary supplements in solid dosage forms. The firm is also engaged in selling sterile ophthalmic pharmaceutical products.
LSL
Intrinsic Value
0.446
CAD
Undervaluation 7%
L
See Also
What is LSL Pharma Group Inc's PP&E Net?
PP&E Net
23m
CAD
23m
CAD
Based on the financial report for Dec 31, 2024, LSL Pharma Group Inc's PP&E Net amounts to 23m CAD.
What is LSL Pharma Group Inc's PP&E Net growth rate?
PP&E Net CAGR 1Y
53%
53%
Over the last year, the PP&E Net growth was 53%.
